Paradigm Shifts and Point-of-Care Decisions for Better Control of Urothelial Carcinoma/Bladder Cancer

Target Audience
This activity is intended for genitourinary and medical oncologists, urologists, oncology advanced practice providers, oncology nurses, internists, primary care physicians, and other clinicians interested/involved in the management of patients with bladder cancer.

Learning Objectives
Upon completion of this activity, participants should be better able to:

A Stratified Approach to Managing NMIBC with Surgical vs Non-Surgical Options
Assess recent safety and efficacy data for current and emerging adjuvant therapies for low-grade NMIBC
Delineate the risks and benefits of low- vs high-intensity cystoscopic surveillance in patients with high-risk NMIBC
Evaluate clinical-trial data for new and investigational agents in the management of patients with high-risk NMIBC